Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 59, Issue 1, 2017, Pages 209-222

  Andreadou, Eleni ^a   Pantazaki, Anastasia A ^a   Daniilidou, Makrina ^a   Tsolaki, Magda ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alzheimer's disease; bacteria; blood serum; cerebrospinal fluid; rhamnolipids

Indexed keywords

CARBON; CHLOROFORM; GLUCONATE SODIUM; HYDROGEN; ORCINOL; POLYCLONAL ANTIBODY; RHAMNOLIPID; RHAMNOSE; SAPONIN; THYMOL; GLYCOLIPID; VIRULENCE FACTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; BACTERIAL VIRULENCE; CARBON SOURCE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; HYDROGEN BOND; IMMUNODETECTION; IMMUNOREACTIVITY; INFRARED SPECTROSCOPY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; SERUM; THERMUS THERMOPHILUS; THIN LAYER CHROMATOGRAPHY; BLOOD; COGNITIVE DEFECT; METABOLISM; PATHOLOGY; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHROMATOGRAPHY, THIN LAYER; COGNITIVE DYSFUNCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOLIPIDS; HUMANS; MALE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VIRULENCE FACTORS;

EID: 85022190084     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-161020     Document Type: Article

References (84)

1. Potgieter M, Bester J, Kell DB, Pretorius E (2015) The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev 39, 567-591.
2. Dinan TG, Stilling RM, Stanton C, Cryan JF (2015) Collective unconscious: How gut microbes shape human behavior. J Psychiatr Res 63, 1-9.
3. Wang Y, Kasper LH (2014) The role of microbiome in central nervous system disorders. Brain Behav Immun 38, 1-12.
4. Stilling RM, Dinan TG, Cryan JF (2015) The brain's Geppetto-microbes as puppeteers of neural function and behaviour J Neurovirol 22, 14-21.
5. Kramer P, Bressan P (2015) Humans as superorganisms: How microbes, viruses, imprinted genes, and other selfish entities shape our behavior. Perspect Psychol Sci 10, 464-481.
6. Sampson TR, MazmanianSK(2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17, 565-576.
7. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC (2015) Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37, 984-995.
8. Coggan KA, Wolfgang MC (2012) Global regulatory pathways and cross-talk control Pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Curr Issues Mol Biol 14, 47-70.
9. Jimenez PN, Koch G, Thompson JA, Xavier KB, Cool RH, Quax WJ (2012) The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 76, 46-65.
10. Rada B, Leto TL (2013) Pyocyanin effects on respiratory epithelium: Relevance in Pseudomonas aeruginosa airway infections. Trends Microbiol 21, 73-81.
11. Zhao Y, Dua P, Lukiw WJ (2015) Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer's disease (AD). J Alzheimers Dis Parkinsonism 5, 177-180.
12. Hill JM, Lukiw WJ (2015) Microbial-generated amyloids and Alzheimer's disease (AD). Front Aging Neurosci 7, 9.
13. Cong X, Henderson WA, Graf J, McGrath JM (2015) Early life experience and gut microbiome: The braingut-microbiota signaling system. Adv Neonatal Care 15, 314-323.
14. Lukiw WJ (2012) Amyloid beta (A-) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opin Emerg Drugs 17, 43-60.
15. Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS (2009) Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 206, 121-124.
16. Pretorius E, Bester J, Kell DB (2016) A bacterial component to Alzheimer's-type dementia seen via a systems biology approach that links iron dysregulation andinflammagen shedding to disease. J Alzheimers Dis 53, 1237-1256.
17. Miklossy J (2015) Historic evidence to support a causal relationship between spirochetal infections and Alzheimer's disease. Front Aging Neurosci 7, 46.
18. Nicolson GL (2008) Chronic bacterial and viral infections in neurodegenerative and neurobehavioral diseases. Labmedicine 39, 290-299.
19. Miklossy J (2011) Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 13, e30.
20. Little CS, JoyceTA, HammondCJ, Matta H, Cahn D, Appelt DM, Balin BJ (2014) Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front Aging Neurosci 6, 304.
21. Miklossy J (2011) Alzheimer's disease-a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 8, 90.
22. Roubaud Baudron C, Varon C, Mégraud F, Salles N (2015) Alzheimer's disease: The infectious hypothesis. Geriatr Psychol Neuropsychiatr Vieil 13, 418-424.
23. Malaguerna M, Bella R, Alagona G, Ferri R, Carnemolla A, Pennisi G (2004) Helicobacter pylori and Alzheimer's disease: A possible link. Eur J Intern Med 15, 381-386.
24. Kountouras J, Zavos C, Boziki M, Gavalas E, Kyriakou P, Deretzi G (2011) Association between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol 258, 2086.
25. Kountouras J, Gavalas E, Polyzos SA, Deretzi G, Kouklakis G, Grigoriadis S, Grigoriadis N, Boziki M, Zavos C, Tzilves D, Katsinelos P (2014) Association between Helicobacter pylori burden and Alzheimer's disease. Eur J Neurol 21, e100.
26. Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S (2013) Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. J Alzheimers Dis 36, 665-677.
27. Singhrao SK, Harding A, Poole S, Kesavalu L, Crean S (2015) Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer's disease. Mediators Inflam 2015, 137357.
28. Kornhuber HH (1996) Propionibacterium acnes in the cortex of patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 246, 108-109.
29. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F (2009) Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77, 120-127.
30. Maier RM, Soberón-Chávez G (2000) Pseudomonas aeruginosa rhamnolipids: Biosynthesis and potential applications. Appl Microbiol Biotechnol 54, 625-633.
31. Vatsa P, Sanchez L, Clement C, Baillieul F, Dorey S (2010) Rhamnolipid biosurfactants as new players in animal and plant defense against microbes. Int J Mol Sci 11, 5095-5108.
32. AbdelMawgoud AMA, Lepine F, Deziel E (2010) Rhamnolipids: Diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol 86, 1323-1336.
33. Abdel-Mawgoud AM, Hausmann R, Lépine F, Muller MM, Déziel E (2011) Rhamnolipids: Detection, analysis, biosynthesis, genetic regulation and bioengineering of production. Biosurf Microbiol Monog 20, 13-55.
34. Piljac G, Piljac V (1995) Immunological activity of rhamnolipids. US Patent 5466675.
35. Zulianello L, Canard C, Köhler T, Caille D, Lacroix JS, Meda P (2006) Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect Immun 74, 3134-3147.
36. Pantazaki AA, Choli-Papadopoulou T (2012) On the Thermus thermophilus HB8 potential pathogenicity triggered from rhamnolipids secretion. Morphological alterations and cytotoxicity induced on fibroblastic cell line. Amino Acids 42, 1913-1926.
37. Giagkas DC, Choli-Papadopoulou T, Pantazaki AA (2013) Development of an antibody for detection of rhamnolipids characterized as a major bacterial virulence factor. Antibodies 2, 501-516.
38. Andreadou E, Moschopoulou A, Simou O, Lialiaris T, Pantazaki A (2016) T. Thermophilus rhamnolipids induce cytogenetic damage on human lymphocytes and bind DNA in vitro. BBJ 10, 1-12.
39. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAwork group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944.
40. Pantazaki AA, Tambaka MG, Langlois V, Guerin P, Kyriakidis DA (2003) Polyhydroxyalkanoate (PHA) biosynthesis in Thermus thermophilus: Purification and biochemical properties of PHA synthase. Mol Cell Biochem 254, 173-183.
41. Pantazaki AA, Papaneophytou CP, Lambropoulou DA (2011) Simultaneous polyhydroxyalkanoates and rhamnolipids production by Thermus thermophilus HB8. AMB Express 1, 1-13.
42. Koch AK, Kappeli O, Ficher A, Reiser J (1991) Hydrocarbon assimilation and biosurfactant production in Pseudomonas aeruginosa mutants. J Bacteriol 173, 4212-4219.
43. Pearson JP, Pesci EC, Iglewski BH (1997) Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol 179, 5756-5767.
44. Schenk T, Schuphan I, Schmidt B (1995) High-performance liquid chromatographic determination of the rhamnolipids produced by Pseudomonas aeruginosa. J Chromatogr A 693, 7-13.
45. Leitermann F, Syldatk C, Hausmann R (2008) Fast quantitative determination of microbial rhamnolipids from cultivation broths by ATR-FTIR Spectroscopy. J Biol Eng 2, 13.
46. Pantazaki AA, Dimopoulou MI, Simou OM, Pritsa AA (2010) Sunflower seed oil and oleic acid utilization for the production of rhamnolipids by Thermus thermophilus HB8. Appl Microbiol Biotechnol 88, 939-995.
47. Meyer-Hoffert U, Zimmermann A, Czapp M, Bartels J, Koblyakova Y, Gläser R, Schröder JM, Gerstel U (2011) Flagellin delivery by Pseudomonas aeruginosa rhamnolipids induces the antimicrobial protein psoriasin in human skin. PLoS One 6, e16433.
48. Soares Dos Santos A, PereiraNJr, FreireDM(2016) Strategies for improved rhamnolipid production by Pseudomonas aeruginosa PA1. Peer J 4, e2078.
49. Laabei M, Jamieson WD, Lewis SE, Diggle SP, Tobias A, Jenkin A (2014) A new assay for rhamnolipid detection-important virulence factors of Pseudomonas aeruginosa. Appl Microbiol Biotechnol 98, 7199-7209.
50. Miklossy J (1993) Alzheimer's disease-a spirochetosis Neuroreport 4, 841-848.
51. Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao Y, Lukiw WJ (2014) Pathogenic microbes, the microbiome, and Alzheimer's disease (AD). Front Aging Neurosci 6, 127.
52. Nayak AS, Vijaykumar MH, Karegoudar TB (2009) Characterization of biosurfactant produced by Pseudoxanthomonas sp. PNK-04 and its application in bioremediation. Int Biodeter Biodegr 63, 73-79.
53. Rooney AP, Price NP, Ray KJ, Kuo TM (2009) Isolation and characterization of rhamnolipid-producing bacterial strains from biodiesel facility. FEMS Microbiol Lett 295, 82-87.
54. Lee M, Kim MK, Vancanneyt M, Swings J, Kim SH, Kang MS, Lee ST (2005) Tetragenococcus koreensis sp. A novel rhamnolipid producing bacterium. Int J Syst Evol Microbiol 55, 1409-1413.
55. Christova N, Tuleva B, Lalchev Z, Jordanova A, Jordanov B (2004) Rhamnolipid biosurfactants produced by Renibacterium salmonarum 27BN during growth on hexadecane. Z Naturforsch 59, 70-74.
56. Christova N, Tuleva B, Nikolova-Damyanova B (2004) Enhanced degradation by a newly isolated Bacillus subtilis strain. Z Naturforsch 59, 205-208.
57. Townsend SM, Hurrell E, Caubilla-Barron J, Loc-Carrillo C, Forsythe SJ (2008) Characterization of an extended-spectrum beta-lactamase Enterobacter hormaechei nosocomial outbreak, and other Enterobacter hormaechei misidentified as Cronobacter (Enterobacter) sakazakii. Microbiology 154, 3659-3667.
58. Brenner DJ, McWhorter AC, Kai A, Steigerwalt AG, Farmer JJ 3rd. (1986) Enterobacter asburiae sp. nov., a new species found in clinical specimens, and reassignment of Erwinia dissolvens and Erwinia nimipressuralis to the genus Enterobacter as Enterobacter dissolvens comb. nov. And Enterobacter nimipressuralis comb. nov. J Clin Microbiol 23, 1114-1120.
59. Häussler S, Nimtz M, Domke T, WrayV, Steinmetz I (1998) Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infect Immun 66, 1588-1593.
60. Dubeau D, Déziel E, Woods D, Lépine F (2009) Burkholderia thailandensis harbours two identical rhl gene clusters responsible for the biosynthesis of rhamnolipids. BMC Microbiol 9, 263.
61. Häussler S, Rhode M, Von Neuhoff N, Nimtz M, Steinmetz I (2003) Structural and functional changes induced by Burkholderia pseudomallei rhamnolipid. Infect Immun 71, 2970-2975.
62. Andrä J, Rademann J, Howe J, Koch MH, Heine H, Zähringer U, Brandenburg K (2006) Endotoxin-like properties of a rhamnolipid exotoxin from Burkholderia (Pseudomonas) plantarii: Immune cell stimulation and biophysical characterization. J Biol Chem 387, 301-310.
63. Biedenbach DJ, Moet GJ, Jones RN (2004) Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997-2002). Diagn Microbiol Infect Dis 50, 59-69.
64. Van Houdt R, Givskov M, Michiels CW (2007) Quorum sensing in Serratia. FEMS Microbiol Rev 31, 407-424.
65. Marinella MA, Warwar R (1998) Endogenous endophthalmitis due to Serratia marcescens. South Med J 91, 388-391.
66. Engel HJ, Collignon PJ, Whiting PT, Kennedy KJ (2009) Serratia sp. bacteremia in Canberra, Australia: A population-based study over 10 years. Eur J Clin Microbiol Infect Dis 28, 821-824.
67. Toribio J, Escalante AE, Soberón-Chávez G (2010) Rhamnolipids: Production in bacteria other than Pseudomonas aeruginosa. Eur J Lipid Sci Technol 112, 1082-1087.
68. Kownatzki R, Tümmler B, Döring G (1987) Rhamnolipid of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. Lancet 1, 1026-1027.
69. Read RC, Roberts P, Munro N, Rutman A, Hastie A, Shryock T, Hall R, McDonald-Gibson W, Lund V, Taylor G (1992) Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol 72, 2271-2277.
70. Kell DB, Pretorius E (2015) On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: The central roles of LPS and LPS-induced cell death. Integr Biol (Camb) 7, 1339-1377.
71. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ (2004) Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis 6, 639-649; discussion 673-81.
72. Paniagua-Contreras G, Sáinz-Espuñes T, Monroy-Pérez E, Raymundo Rodrguez-Moctezuma J, Arenas-Aranda D, Negrete-Abasca E, Vaca1 S (2012) Virulence markers in Staphylococcus aureus strains isolated from hemodialysis catheters of Mexican patients. Adv Microbiol 2, 476-487.
73. Gonzalez-Juarrero M, Mima N, Trunck LA, Schweizer HP, Bowen RA, Dascher K, Mwangi W, Eckstein TM (2013) Polar lipids of Burkholderia pseudomallei induce different host immune responses. PLoS One 8, e80368.
74. Nishimori JH, NewmanTN, Oppong GO, Rapsinski GJ, Yen JH, Biesecker SG, Wilson RP, Butler BP, Winter MG, Tsolis RM, Ganea D, Tukel C (2012) Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa. Infect Immun 80, 4398-4408.
75. Tukel C, Nishimori JH, Wilson RP, Winter MG, Keestra AM, van Putten JP, Baumler AJ (2010) Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms. Cell Microbiol 12, 1495-1505.
76. Gerstel U, Czapp M, Bartels J, Schröder JM (2009) Rhamnolipid-induced shedding of flagellin from Pseudomonas aeruginosa provokes hBD-2 and IL-8 response in human keratinocytes. Cell Microbiol 11, 842-853.
77. Schwartz K, Boles BR (2013) Microbial amyloids-functions and interactions within the host. Curr Opin Microbiol 16, 93-99.
78. Gebbink MF, Claessen D, Bouma B, Dijkhuizen L, Wösten HA(2005) Amyloids-a functional coat for microorganisms. Nat Rev Microbiol 3, 333-341.
79. Van Gerven N, Klein RD, Hultgren SJ, Remaut H (2015) Bacterial amyloid formation: Structural insights into curli biogenesis. Trends Microbiol 23, 693-706.
80. Davey ME, Caiazza NC, O'Toole GA (2003) Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185, 1027-1036.
81. Caiazza NC, Shanks RM, O'Toole GA (2005) Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa. J Bacteriol 187, 7351-7361.
82. Bukowska-Ósko I, Perlejewski K, Nakamura S, Motooka D, Stokowy T, Kosínska J, Popiel M, Ploski R, Horban A, Lipowski D, Caraballo Cortés K, Pawelczyk A, Demkow U, Stepién A, Radkowski M, Laskus T (2017) Sensitivity of next-generation sequencing metagenomic analysis for detection of RNA and DNA viruses in cerebrospinal fluid: The confounding effect of background contamination. Adv Exp Med Biol 944, 53-62.
83. Jovel J, O'keefe S, Patterson J, Bording-Jorgensen M, Wang W, Mason AL, Warren KG, WongGK(2017) Cerebrospinal fluid in a small cohort of patients with multiple sclerosis was generally free of microbial DNA. Front Cell Infect Microbiol 6, 198.
84. Tsolaki MN, Koutsouraki E, Katsipis GK, Myserlis PGr., ChatzithomaMAand PantazakiAA(2017) Alternative antiinfective/ anti-inflammatory therapeutic options for fighting Alzheimer's disease. In Frontiers in Anti-Infective Drug Discovery, 6, Atta-ur-Rahman, Iqbal Choudhary M, eds. Bentham Science Publishers, Sharjah, UAE, pp. 3-161.